Highlights:
-Are “off-the-shelf” fenestrated endografts seeing a new dawn?
-Lower restenosis and re-occlusion rates with drug-eluting balloons compared to angioplasty in DEBATE-BTK
-Dismantling the different myths around the CREST trial
-Profile: Patrick Peeters
(Visited 42 times, 1 visits today)
